Fears over a medical gold rush in cancer drug race – Financial Times

Fears over a medical gold rush in cancer drug race
Financial Times
It might sound like a strange complaint against an industry often accused of scrimping on research to fund marketing efforts, but some executives and scientists say drugmakers are doing too many clinical trials in the hot new field of immunotherapy …